BDBM46481 2-(3-keto-6-morpholinosulfonyl-1,4-benzoxazin-4-yl)-N-(2-pyridylmethyl)acetamide::2-(6-morpholin-4-ylsulfonyl-3-oxidanylidene-1,4-benzoxazin-4-yl)-N-(pyridin-2-ylmethyl)ethanamide::2-(6-morpholin-4-ylsulfonyl-3-oxo-1,4-benzoxazin-4-yl)-N-(pyridin-2-ylmethyl)acetamide::2-[6-(4-morpholinylsulfonyl)-3-oxo-1,4-benzoxazin-4-yl]-N-(2-pyridinylmethyl)acetamide::2-[6-(morpholin-4-ylsulfonyl)-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl]-N-(pyridin-2-ylmethyl)acetamide::MLS000674702::SMR000314143::cid_16189325
SMILES C=CC(=O)N1CCc2nn(-c3ccc(C4CC4)cc3O)c3c2C(C1)N(C(=O)c1nnc(C(F)(F)F)cc1N)CC3
InChI Key InChIKey=PGRRIXRCXBMOOT-UHFFFAOYSA-N
Data 2 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 46481
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [2-1432](Human)
Moma Therapeutics
US Patent
Moma Therapeutics
US Patent
Affinity DataIC50: 1.5nMAssay Description:Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute, TSRI Assay ...More data for this Ligand-Target Pair
TargetBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN [2-1432](Human)
Moma Therapeutics
US Patent
Moma Therapeutics
US Patent
Affinity DataIC50: 3.25nMAssay Description:Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute, TSRI Assay ...More data for this Ligand-Target Pair
